期刊文献+

病毒型肝炎相关性肝癌的临床病理特征分析 被引量:5

原文传递
导出
摘要 目的探讨乙型肝炎病毒相关性肝癌与丙型肝炎病毒相关性肝癌的临床病理特征。方法回顾性分析本科室确诊为乙型肝炎病毒(HBV)或丙型肝炎病毒(HCV)感染相关的肝癌(HCC)两组患者117例,两组问对照分析,比较两组的临床病理特征。结果HCV.HCC组年龄高于HBV—HCC组(P〈0.01),HCV—HCC组患者中48.8%的有血液接触史,HBV—HCC组患者54.1%的有家族史;HBV—HCC组的AFP值高于HCV—HCC组(P〈0.01),HCV—HCC者的肿瘤直径[(4.1±5.2)cm]小于HBV.HCC者[(6.4±5.5)cm,P〈0.05]。HCV—HCC组中88.4%患者有肝硬化,肿瘤包膜完整率HCV-HCC组高于HBV.HCC组(39.5%VS20.3%,P〈0.05),癌栓发生率HCV—HCC明显低于HBV—HCC组(14.0%VS32.4%,P〈0.05);弥漫型肝癌只发生HBV.HCC组(4.1%),属乏血供肝癌;两组患者性别、ALT、TBIL、ALB及胛比较差异均无统计学意义(P〉0.05)。结论乙型肝炎病毒相关性肝癌与丙型肝炎病毒相关性肝癌的许多临床病理特征差异具有统计学意义。
出处 《中国医师杂志》 CAS 2013年第2期213-215,共3页 Journal of Chinese Physician
  • 相关文献

参考文献14

二级参考文献16

  • 1Seung Oe Lim,Sung Gyoo Park,Jun-Hi Yoo,Young Min Park,Hie-Joon Kim,Kee-Taek Jang,Jae Won Cho,Byung Chul Yoo,Gu-Hung Jung,Cheol Keun Park.Expression of heat shock proteins (HSP27, HSP60, HSP70, HSP90, GRP78, GRP94) in hepatitis B virus-related hepatocellular carcinomas and dysplastic nodules[J].World Journal of Gastroenterology,2005,11(14):2072-2079. 被引量:62
  • 2Ruis J,Sangro B,Cuende JI,et al.Hepatitis B and C viral infection in patients with hepatocellular carcinoma[J].Hepatology,1992,16:637-641.
  • 3Guo JT,Zhou H,Liu C,et al.Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections[J].J Virol,2000,74:1495-1505.
  • 4Huo TI,Huang YH,Hsia CY,et al.Characteristics and outcome of patients with dual hepatitis B and C-associated hepatocellular carcinoma:are they different from patients with single virus infection[J].Liver International,2009,29:767-773.
  • 5Massimo C.Natural history and pathogenesis of hepatitis C virus related hepatocellular carcinoma[J].Journal of Hepatology,1999,31:25-30.
  • 6Sun HC,Zhang W,Qin LX,et al.Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma[J].Hepatol,2007,47:684-690.
  • 7Roayaie S,Haim MB,Emre S,et al.Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C:a Western experience[J].Ann Surg Oncol,2000,7:764-770.
  • 8Ahmad SA,Bilimoria MM,Wang X.Hepatitis B or C Virus Serology as a prognostic Factor in Patients With Hepatocellular Carcinoma[J].J Gastrointest Surg,2001,5:468-476.
  • 9Chen CH,Huang GT,Yang PM,et al.Hepatitis B-and C-related hepatocellular carcinomas yield different clinical features and prognosis[J].Eur J Cancer,2006,42:2524-2529.
  • 10[1]Beasley RP.Hepatits B virus:the major etiology of hepatocellullarcarcinoma.Cancer,1988,61 (10):1942-1948.

共引文献1042

同被引文献32

  • 1李颖,丁洋,王雪莲,刘沛.慢性丙型肝炎患者血清HCV RNA,ALT与肝脏病理间的关系[J].世界华人消化杂志,2006,14(9):916-919. 被引量:24
  • 2Felmlee DJ, Hafirassou ML, Lefevre M, et al. Hepatitis C virus, cholesterol and lipoproteins-impact for the viral life cycle and pathogenesis of liver disease. Viruses, 2013, 5(5):1292-1324.
  • 3Aizawa Y, Shimada N, Abe H, et al. Serum lipoprotein profiles and response to pegylated interferon plus ribavirin combination therapy in patients with chronic HCV genotype lb infection. Hepat Mon, 2013, 13(5):e8988-8994.
  • 4Guo CH, Chen PC, Ko WS. Status of essential trace minerals and oxidative stress in viral hepatitis C patients with nonalcoholic fatty liver disease. IntJ Med Sci, 2013, 10(6):730-737.
  • 5Jain S,Singhal S,Lee P,Xu R.Molecular genetics of hepatocellular neoplasia.Am J Transl Res,2010,2(1):105-118.
  • 6Ozkan H,Erdal H,Kogak E,Tutkak H,Karaeren Z,Yakut M,Koklii S.Diagnostic and prognostic role of serum glypican 3 in patients with hepatocellular carcinoma.J Clin Lab Anal, 2011,25(5):350-353.
  • 7Yan B,Wei JJ,Qian YM,Zhao XL,Zhang WW,Xu AM,Zhang SH.Expression and clinicopathologic significance of glypican 3 in hepatocellular carcinoma.Ann Diagn Pathol,2011,15(3):162-169.
  • 8Abdul-Al HM,Makhlouf HR,Wang G,Goodman ZD.Glypican-3 expression in benign liver tissue with active hepatitis C:implicationsfor the diagnosis of hepatocellular carcinoma. Hum Pathol,2008,39(2):209-212.
  • 9Leistner CM,Gruen-Bernhard S,Glebe D.Role of glycosaminoglycans for binding and infection of hepatitis B vims.Cell Microbiol,2008,10(1):122-133.
  • 10Andreo U,Maillard P,Kalinina 0,Walic M,Meurs E,Martinot M,Marcellin P,Budkowska A.Lipoprotein lipase mediates hepatitis C vims (HCV) cell entry and inhibits HCV infection.Cell Microbiol,2007,9(10):2445-2456.

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部